Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?
作者信息
Northcote R J
机构信息
Royal Infirmary, Glasgow.
出版信息
Br Med J (Clin Res Ed). 1988 Mar 12;296(6624):731-2. doi: 10.1136/bmj.296.6624.731.
Abstract
摘要
相似文献
1
Beta blockers, lipids, and coronary atherosclerosis: fact or fiction?β受体阻滞剂、血脂与冠状动脉粥样硬化：事实还是虚构？
Br Med J (Clin Res Ed). 1988 Mar 12;296(6624):731-2. doi: 10.1136/bmj.296.6624.731.
2
[The metabolic side effects of beta-receptor blockers].[β受体阻滞剂的代谢副作用]
Dtsch Med Wochenschr. 1992 Oct 16;117(42):1617-8.
3
Recent studies on the effects of beta blockers on blood lipid levels.近期关于β受体阻滞剂对血脂水平影响的研究。
Am Heart J. 1989 Mar;117(3):709-14. doi: 10.1016/0002-8703(89)90757-6.
4
[Lipoprotein metabolism and beta receptor blockers].[脂蛋白代谢与β受体阻滞剂]
Z Gesamte Inn Med. 1987 Apr 15;42(8):201-5.
5
[Changes in lipids and lipoproteins caused by the beta-blocking agents used as antihypertensives].[用作抗高血压药物的β受体阻滞剂引起的脂质和脂蛋白变化]
J Pharmacol. 1983;14 Suppl 2:183-99.
6
[Beta-adrenergic inhibitors and atherogenic risk].[β-肾上腺素能抑制剂与动脉粥样硬化风险]
Therapie. 1985 Nov-Dec;40(6):387-91.
7
Beta-blockers, plasma lipids, and coronary heart disease.β受体阻滞剂、血脂与冠心病
Circulation. 1990 Sep;82(3 Suppl):II60-5.
8
Is there any reason to withhold beta blockers from high-risk patients with coronary artery disease during surgery?对于患有冠状动脉疾病的高危患者，在手术期间停用β受体阻滞剂有什么理由吗？
Anesthesiology. 2004 Jan;100(1):4-7. doi: 10.1097/00000542-200401000-00004.
9
[Effect of hypotensive agents on the lipid composition of the blood].[降压药对血液脂质成分的影响]
Ter Arkh. 1985;57(11):138-42.
引用本文的文献
1
Long-term effect of pindolol on lipids and lipoproteins in men with newly diagnosed hypertension.
Eur J Clin Pharmacol. 1989;36(4):347-50. doi: 10.1007/BF00558293.
2
Beta-adrenoceptor partial agonists: a renaissance in cardiovascular therapy?β-肾上腺素能受体部分激动剂：心血管治疗的复兴？
Br J Clin Pharmacol. 1990 Aug;30(2):157-71. doi: 10.1111/j.1365-2125.1990.tb03760.x.
3
The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.慢性心血管危险因素综合征（X综合征）：动脉粥样硬化的机制及影响
Postgrad Med J. 1991 Oct;67(792):922-7. doi: 10.1136/pgmj.67.792.922.
本文引用的文献
1
The role of hypertension and downward changes of blood pressure in the genesis of coronary atherosclerosis and acute myocardial ischemic attacks.高血压及血压下降在冠状动脉粥样硬化形成和急性心肌缺血发作中的作用。
Am Heart J. 1982 Apr;103(4 Pt 1):579-82. doi: 10.1016/0002-8703(82)90353-2.
2
Bronchodilator activity of prazosin in patients with allergic rhinitis and asthma.哌唑嗪对过敏性鼻炎和哮喘患者的支气管扩张作用。
Br J Clin Pharmacol. 1982 Mar;13(3):445-8. doi: 10.1111/j.1365-2125.1982.tb01400.x.
3
Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.轻度高血压的治疗：一项为期五年的对照药物试验。奥斯陆研究。
Am J Med. 1980 Nov;69(5):725-32. doi: 10.1016/0002-9343(80)90438-6.
4
Thiazides, beta blockers and lipoproteins.噻嗪类利尿剂、β受体阻滞剂与脂蛋白
Postgrad Med J. 1983 Aug;59(694):483-8. doi: 10.1136/pgmj.59.694.483.
5
Multivariate analysis of risk factors for coronary heart disease.
Circulation. 1973 Nov;48(5):950-8. doi: 10.1161/01.cir.48.5.950.
6
The effects of propranolol on cholesterol-induced atheromatous lesions.普萘洛尔对胆固醇诱导的动脉粥样硬化病变的影响。
Atherosclerosis. 1973 Sep-Oct;18(2):337-45. doi: 10.1016/0021-9150(73)90109-3.
7
Effects of propranolol on atherogenesis in the cholesterol-fed rabbit.
Circ Res. 1985 May;56(5):755-62. doi: 10.1161/01.res.56.5.755.
8
9
Beta-adrenoceptor blockade and plasma lipoproteins. Comparison of the effects of propranolol and pindolol on plasma lipoproteins including high-density lipoprotein subfractions.β-肾上腺素能受体阻滞与血浆脂蛋白。普萘洛尔和吲哚洛尔对包括高密度脂蛋白亚组分在内的血浆脂蛋白影响的比较。
Clin Sci (Lond). 1987 May;72(5):549-56. doi: 10.1042/cs0720549.
10
Randomised trial of treatment of hypertension in elderly patients in primary care.老年患者原发性高血压治疗的随机试验
Br Med J (Clin Res Ed). 1986 Nov 1;293(6555):1145-51. doi: 10.1136/bmj.293.6555.1145.
Zotero 插件